Study guide

3.2 Evidence-Based Assessment Instruments

IC&RC Advanced Alcohol & Drug Counselor AADC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Master's-Level Credentialing

1.1 IC&RC AADC Exam Purpose, Structure & Scoring 1.2 Master's-Level Preparation Strategy & Exam Blueprint Navigation

2 Chapter 2: Diagnostic Systems & DSM-5-TR Substance Use Disorders

2.1 DSM-5-TR Diagnostic Criteria & Severity Continuum 2.2 Substance Classes, Intoxication & Withdrawal Syndromes 2.3 Neurobiology of Addiction & Tolerance Mechanics

3 Chapter 3: Standardized Screening, Comprehensive Assessment & Diagnostic Feedback

3.1 Clinical Distinctions Between Screening and Assessment 3.2 Evidence-Based Assessment Instruments 3.3 Selecting Culturally Appropriate Screening and Assessment Tools 3.4 Biopsychosocial Intake Interviewing & Stage-of-Change Assessment 3.5 Documenting Screening and Assessment Results 3.6 Discussing Diagnostic Results and Recommendations

4 Chapter 4: Complex Co-Occurring Psychiatric Disorders & Differential Diagnosis

4.1 Differential Diagnosis Principles: Primary vs Substance-Induced Disorders 4.2 Co-Occurring Depressive, Bipolar & Anxiety Disorders 4.3 Personality Disorders, PTSD & Severe Mental Illness

5 Chapter 5: Trauma, Suicide Risk & Crisis Engagement

5.1 Trauma Assessment & Complex Post-Traumatic Stress 5.2 Lethality & Suicide Risk Formulation 5.3 Crisis Intervention & Motivational Engagement

6 Chapter 6: ASAM Criteria & Multidimensional Level of Care Placement

6.1 ASAM Six Assessment Dimensions 6.2 ASAM Continuum of Care Levels 6.3 Level-of-Care Transitions, Continued Stay & Discharge

7 Chapter 7: Treatment Planning & SMART Goal Formulation

7.1 Problem Identification & Clinical Formulation 7.2 SMART Goals, Objectives & Interventions 7.3 Treatment Plan Evolution, Ongoing Review & Documentation 7.4 Educating the Person Served About the Counseling Process

8 Chapter 8: Pharmacotherapy & Medications for Substance Use Disorders

8.1 Medications for Opioid Use Disorder (MOUD) 8.2 Medications for Alcohol and Tobacco Use Disorders 8.3 Psychiatric Pharmacotherapy & The Counselor's Role

9 Chapter 9: Interprofessional Collaboration, Care Coordination & Referral

9.1 Multidisciplinary Teamwork & Integrated Healthcare 9.2 Referral Processes & Continuity of Care 9.3 Coordination with Specialized Systems

10 Chapter 10: Cognitive Behavioral Therapy & Relapse Prevention

10.1 Theoretical Foundations of CBT in Addiction 10.2 Cognitive Restructuring & Behavioral Coping Skills 10.3 Relapse Prevention Models & The Abstinence Violation Effect 10.4 Community Reinforcement & Third-Wave CBT Approaches

11 Chapter 11: Motivational Interviewing & Motivational Enhancement Therapy

11.1 Spirit & Foundational Principles of Motivational Interviewing 11.2 Four Processes & OARS Core Clinical Skills 11.3 Motivational Enhancement Therapy Protocol & Change Talk

12 Chapter 12: Contingency Management, Twelve-Step Facilitation & Third-Wave Behavioral Approaches

12.1 Operant Conditioning & Contingency Management Protocols 12.2 Twelve-Step Facilitation (TSF) Therapy 12.3 Mindfulness-Based Relapse Prevention (MBRP) & Acceptance Approaches 12.4 Multiple Pathways of Recovery & Adapting Intervention Strategies

13 Chapter 13: Family Systems, Adolescent Considerations & Group Psychotherapy

13.1 Family Systems Approaches in Addiction Treatment 13.2 Adolescent-Specific Assessment & Evidence-Based Interventions 13.3 Group Psychotherapy Dynamics & Facilitation

14 Chapter 14: Psychoeducation, Health Promotion & Infectious Disease

14.1 Medical & Health Consequences of Chronic Substance Use 14.2 Infectious Diseases: HIV/AIDS, Viral Hepatitis & STI Transmission 14.3 Wellness, Lifestyle Modification & Holistic Recovery Support

15 Chapter 15: Confidentiality, 42 CFR Part 2 & Legal Mandates

15.1 Federal Confidentiality Laws: 42 CFR Part 2 Foundations 15.2 Comparing 42 CFR Part 2 and HIPAA: Consent & Disclosures 15.3 Medical Emergencies, Child/Elder Abuse & Mandated Reporting 15.4 Duty to Warn (Tarasoff) & Responding to Subpoenas and Court Orders

16 Chapter 16: Clinical Supervision Models, Competency Evaluation & Gatekeeping

16.1 Theoretical Frameworks & Models of Clinical Supervision 16.2 The Supervisory Relationship, Roles & Modalities 16.3 Competency Evaluation, Formative Feedback & Gatekeeping 16.4 Vicarious Liability, Legal Risks & Managing Impaired Counselors

17 Chapter 17: Professional Ethics, Boundaries & Multicultural Competence

17.1 Professional Codes of Ethics & Ethical Decision-Making Frameworks 17.2 Dual Relationships, Professional Boundaries & Conflict of Interest 17.3 Multicultural Competence, Cultural Humility & Health Disparities 17.4 Technology, Telehealth & Digital Ethics in Addiction Counseling 17.5 Integrating Research Into Clinical Practice

3.2 Evidence-Based Assessment Instruments

Key Takeaways Explain This Topic AI

The AUDIT is the gold-standard 10-item World Health Organization screen evaluating alcohol consumption, dependence symptoms, and related consequences across four distinct risk zones.

The DAST-10 is a 10-item instrument assessing non-alcohol drug misuse over the past 12 months, stratifying patients into low, moderate, substantial, and severe clinical action levels.

CAGE and CAGE-AID utilize a 2-point threshold indicating high risk of addiction, though their lifetime framing limits sensitivity to early-stage or recent hazardous consumption.

CRAFFT 2.1 is validated for adolescents aged 12 to 21 with a cutoff of 2 or more, uniquely incorporating motor vehicle safety contracting regarding substance-impaired driving.

The Addiction Severity Index (ASI) evaluates 7 functional life domains, producing mathematically derived objective Composite Scores and subjective clinician Interviewer Severity Ratings.

Last updated: September 2026

3.2 Evidence-Based Assessment Instruments

Master's-level addiction counselors must base their diagnostic formulations on psychometrically validated, standardized instruments rather than unstructured clinical intuition. Standardized instruments establish diagnostic reliability, reduce cultural and clinician bias, quantify clinical severity, and provide objective baselines for measuring longitudinal treatment progress. The IC&RC AADC examination requires advanced clinicians to demonstrate mastery across general, adolescent, perinatal, and comprehensive multidimensional assessment tools.

1. Alcohol Screening Instruments: AUDIT and AUDIT-C

Developed by the World Health Organization (WHO), the Alcohol Use Disorders Identification Test (AUDIT) is considered the international gold standard for screening across diverse healthcare and clinical settings. AUDIT Total Score (0 - 40)

  • ┌─────────────────┬──────────────────┬──────────────────┬─────────────────┐
  • │ Zone I (0-7) │ Zone II (8-15) │ Zone III (16-19) │ Zone IV (20-40) │
  • │ Low Risk │ Hazardous Use │ Harmful Use │ Severe / Depend │
  • │ Alcohol Educ. │Brief Intervention│Brief Tx / Monitor│Specialty Referr.│
  • └─────────────────┴──────────────────┴──────────────────┴─────────────────┘
  • The Full 10-Item AUDIT

The 10 items of the AUDIT are partitioned into three distinct clinical conceptual domains:

Hazardous Alcohol Consumption (Items 1–3): Frequency of drinking, typical quantity consumed per drinking day, and frequency of heavy episodic drinking (binge drinking: ≥ 6 \ge 6 ≥ 6 standard drinks on one occasion).

Dependence Symptoms (Items 4–6): Impaired control over drinking, increased salience of drinking (failing to do what was normally expected), and morning drinking to relieve withdrawal (eye-opener).

Harmful Alcohol Use / Consequences (Items 7–10): Post-drinking guilt or remorse, alcohol-related blackouts/amnesia, alcohol-related physical injury (to self or others), and family/physician concern regarding drinking.

Each item is scored from 0 to 4, yielding a total score range of 0 to 40 .

Cutoff Score ≥ 8 \ge 8 ≥ 8 : Indicates hazardous and harmful alcohol use (sensitivity ~92%, specificity ~94% in adult populations). In women and adults over age 65, many clinical guidelines recommend a lower cutoff of ≥ 7 \ge 7 ≥ 7 or ≥ 5 \ge 5 ≥ 5 to account for physiological differences in alcohol metabolism and lower body water volume.

Cutoff Score ≥ 15 \ge 15 ≥ 15 : Strongly suggests moderate-to-severe alcohol use disorder and physical dependence, necessitating comprehensive diagnostic assessment.

The Abbreviated AUDIT-C

The AUDIT-C consists solely of the first 3 consumption questions of the full AUDIT, scored from 0 to 12 points. It serves as an ultra-rapid screen in fast-paced clinical settings (e.g., emergency departments, routine outpatient medical visits).

Clinical Cutoffs:

Men: A score of ≥ 4 \ge 4 ≥ 4 indicates hazardous drinking / positive screen.

Women and Older Adults ( ≥ 65 \ge 65 ≥ 65 ): A score of ≥ 3 \ge 3 ≥ 3 indicates hazardous drinking / positive screen.

A positive AUDIT-C should immediately trigger administration of the remaining 7 items of the full AUDIT or direct clinical referral for a comprehensive assessment.

2. Drug Abuse Screening Test: DAST-10

The DAST-10 , adapted by Harvey Skinner from the original 28-item instrument, is a brief, 10-item self-report questionnaire assessing drug misuse (prescribed medications taken in excess or non-medically, and illicit substances) over the past 12 months . It explicitly excludes alcohol and tobacco.

Items are answered in a Yes/No binary format. Each affirmative response scores 1 point, with the exception of Item 3 ( "Can you get through the week without using drugs?" ), where a "No" response scores 1 point.

DAST-10 Scoring Strata and Clinical Action Guidelines

  • Score Severity Category Recommended Clinical Action
  • 0 No problem reported None; annual re-screening as indicated
  • 1 – 2 Low level of problem Brief intervention, health education, harm-reduction counseling

3 – 5 Moderate level of problem Extended brief intervention, comprehensive biopsychosocial assessment, outpatient therapy

6 – 8 Substantial level of problem Intensive outpatient (IOP) or partial hospitalization placement, psychiatric evaluation

9 – 10 Severe level of problem Intensive residential treatment, specialized inpatient addiction referral, medical management

3. Legacy and Acronym-Based Instruments: CAGE and CAGE-AID

The CAGE is an iconic 4-item screening questionnaire developed by John Ewing:

C — Cut down: Have you ever felt you ought to C ut down on your drinking?

A — Annoyed: Have people A nnoyed you by criticizing your drinking?

G — Guilty: Have you ever felt bad or G uilty about your drinking?

E — Eye-opener: Have you ever had a drink first thing in the morning to steady your nerves or get rid of a hangover ( E ye-opener)?

CAGE-AID (Adapted to Include Drugs)

The CAGE-AID incorporates drug use into each prompt (e.g., "Have you ever felt you ought to cut down on your drinking or drug use?" ).

Scoring: Scored 0 to 4. A score of ≥ 2 \ge 2 ≥ 2 positive responses is clinically significant, demonstrating high specificity (80%–95%) for lifetime substance dependence.

Clinical Limitations for Advanced Practice: The CAGE/CAGE-AID focuses on lifetime history rather than current use patterns. It demonstrates poor sensitivity for detecting early-stage hazardous drinking, episodic binge drinking, or recent behavioral change. Consequently, while widely recognized, it is considered inferior to the AUDIT for universal early-intervention screening.

  • 4. Specialized Population Screens: CRAFFT, T-ACE, and TWEAK
  • Adolescent Screening: The CRAFFT 2.1

Validated specifically for adolescents aged 12 to 21 , the CRAFFT 2.1 begins with three opening questions regarding past-12-month use of alcohol, cannabis, or other substances. If the adolescent answers "No" to all three, only the "Car" question is asked. If the adolescent answers "Yes" to any opening question, all six CRAFFT questions are administered:

C — Car: Have you ever ridden in a C ar driven by someone (including yourself) who was "high" or had been using alcohol or drugs?

R — Relax: Do you ever use alcohol or drugs to R elax, feel better about yourself, or fit in?

A — Alone: Do you ever use alcohol or drugs while you are by yourself, A lone?

F — Forget: Do you ever F orget things you did while using alcohol or drugs?

F — Friends: Do your family or F riends ever tell you that you should cut down on your drinking or drug use?

T — Trouble: Have you ever gotten into T rouble while you were using alcohol or drugs?

Important

Clinical Interpretation: A CRAFFT score of ≥ 2 \ge 2 ≥ 2 indicates high risk for a substance use disorder and necessitates a comprehensive clinical assessment. Crucially, an affirmative response to the Car item demands immediate, non-punitive safety planning and a contract for life regarding motor vehicle transportation.

Perinatal Alcohol Screening: T-ACE and TWEAK

Standard alcohol screens exhibit reduced sensitivity during pregnancy because social desirability bias leads women to minimize self-reported volume. The T-ACE and TWEAK overcome this barrier by heavily weighting physiological tolerance:

T-ACE (4 items, Range 0–5):

Tolerance (T): "How many drinks does it take to make you feel high?" ( ≥ 2 \ge 2 ≥ 2 drinks scores 2 points ).

Annoyed (A): Have people annoyed you by criticizing your drinking? (1 point).

Cut down (C): Have you felt you ought to cut down? (1 point).

Eye-opener (E): Morning drink to steady nerves? (1 point).

Cutoff: A score of ≥ 2 \ge 2 ≥ 2 points indicates risk drinking during pregnancy.

TWEAK (5 items, Range 0–7):

Tolerance (T): Takes ≥ 3 \ge 3 ≥ 3 drinks to feel high (scores 2 points ).

Worried (W): Friends/family worried or complained (scores 2 points ).

Eye-opener (E): Morning drink (scores 1 point ).

Amnesia (A): Blackouts / memory loss (scores 1 point ).

K(C)ut down (K): Felt need to cut down (scores 1 point ).

Cutoff: A score of ≥ 2 \ge 2 ≥ 2 points indicates high risk for alcohol-exposed pregnancy.

5. Comprehensive Multidimensional Evaluation: The Addiction Severity Index (ASI)

The Addiction Severity Index (ASI) (5th and 6th editions, developed by McLellan and colleagues) is the premier semistructured clinical intake and research interview in addiction science. The ASI assesses dysfunction across seven functional problem domains : ┌─────────────────────┐

  • │ Medical Status │
  • ├─────────────────────┤
  • │ Employment / Support│
  • ├─────────────────────┤
  • │ Alcohol Use │
  • ├─────────────────────┤
  • │ Drug Use │
  • ├─────────────────────┤
  • │ Legal Status │
  • ├─────────────────────┤
  • │ Family / Social Rel │
  • ├─────────────────────┤
  • │ Psychiatric Status │
  • └─────────────────────┘
  • Temporal Evaluation

The ASI systematically collects two time frames across each domain:

Lifetime History: Measures historical chronicity, developmental onset, and lifetime problem density.

Past 30 Days: Measures current acute impairment, immediate distress, and baseline acuity for pre/post treatment comparison.

Dual Scoring Methodologies: Composite Scores vs. Interviewer Severity Ratings

Composite Scores (CS):

Objective, mathematically calculated indices ranging from 0.00 to 1.00 .

Derived from predetermined formulas weighting specific past-30-day items.

Highly reliable, eliminating clinician subjectivity; utilized primarily for empirical research, program evaluation, and longitudinal outcome measurement.

Interviewer Severity Ratings (ISR):

Subjective clinical ratings assigned by the credentialed interviewer on a 0 to 9 scale (0–1: no problem/no treatment needed; 8–9: extreme problem/treatment life-prescribed).

Synthesizes the client's past-30-day symptoms, lifetime history, subjective distress, and observable behavioral impairment to quantify the client's current need for additional treatment in that specific domain.